Metabolic syndrome among pre and post-menopausal women according to NCEP ATP-III & IDF criteria: A comparative analysis

Khalida Shaikh; Zulfiqar Ali Laghari; Jamshed Warsi

Abstract
Objective: To compare the prevalence of metabolic syndrome (MetS) amongst pre- menopausal and post-menopausal women according to NCEP: ATPIII & International Diabetes Federation (IDF) criteria.
Methodology: This cross-sectional study was done on a sample of 278 (147 premenopausal & 131 postmenopausal) women (25 years and above) presenting to the Outpatient Department of Liaquat University Hospital, Hyderabad from February to October 2020. We used a structured interview-based questionnaire containing inquiries pertaining to basic biodata, sociodemographic details and menstrual history. All anthropometric measurements along with visceral & body fat level were calculated using measuring tape & OMRON BfF508. Data were analyzed using SPSS 23.
Results: Cumulative MetS prevalence was 63.7% and 57.6% according to IDF (WC80 diagnostic criteria) and NCEP ATP-III classifications, respectively. Prevalence of MetS in premenopausal, was 24.5% according to IDF criteria and 21.24% according to ATP-III, criteria. Among postmenopausal, prevalence of MetS was 39.2% according to IDF criteria, and 36.36 according to NCEP ATP-III criteria.
Conclusion: MetS is more common among post-menopausal women. It is also observed in pre-menopausal women at alarming rates. IDF suggests significantly higher prevalence of MetS in participants as compared to ATP III criteria.

Key words: Metabolic syndrome, menopause, visceral & body Fat, NCEP ATP-III Classification, IDF Criteria.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in Scopus, Web of Science, WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Tehqeeqat

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements